Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 08 oct 2021 - 07:00
- Statutory name argenx SE
- Title argenx to Highlight Potential First-in-Class FcRn Antagonist Efgartigimod at Upcoming Neuromuscular Meetings
|202110080000000001_argenx Press Release-AANEM 2021 Curtain Raiser FINAL.pdf|
Date last update: 22 January 2022